LyondellBasell: 5 Reasons To Brace For More Pain (Archive) Industry downcycle, weak cash flows and delayed growth projects keep LYB’s risk elevated.
Palantir: Why I Think It Can Still Go Up 9x (Archive) Palantir can still be a 9x multibagger despite demanding growth expectations.
Rigetti Computing: Here's What Needs To Happen For Its Valuation To Make Sense (Archive) Balancing speculative quantum hype against fragile fundamentals and dilution-driven valuation math.
Intel: I Got This Wrong But Here's Why I'm Still Not Buying Yet (Archive) Intel’s lifeline is secured funding, but chronic execution risks still restrain genuine upside.
IonQ: Turning Bullish After A Disastrous Bear Call (Archive) FOMO-driven IonQ bet: cautious optimism on M&A growth, valuation, liquidity and momentum tailwinds.
UnitedHealth: This Rally Is Lacking Substance; Sell Now (Archive) Rally driven by hype, margin pressure, and legal risk makes UNH a sell.
Nvidia: Top 5 Reasons To Keep Buying (Archive) Nvidia accelerates annual AI chip launches to power mega-growth themes in agentic, industrial AI.